Anna-Maria Larsson
31 – 35 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2012
-
Mark
Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
Larsson, Anna-Maria LU ; Jirström, Karin LU
; Fredlund, Erik
LU
; Björner, Sofie
LU
; Rydén, Lisa
LU
; Landberg, Göran
LU
and Påhlman, Sven
LU
(2009)
In Clinical Cancer Research
15(17).
p.5552-5559
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska, Karolina LU ; Larsson, Anna-Maria LU ; Holmquist Mengelbier, Linda LU ; Bridges Baxter, Esther LU ; Fredlund, Erik LU ; Borgquist, Signe LU ; Landberg, Göran LU ; Påhlman, Sven LU and Jirström, Karin LU
(2008)
In Cancer Research
68(22).
p.9212-9220
- Contribution to journal › Article
- 2005
-
Mark
Epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-related anemia in cancer patients in sweden: comparative analysis of drug utilization, costs, and hematologic response.
- Contribution to journal › Article
- 2004
-
Mark
Erythropoietin enhances response to treatment in patients with advanced breast cancer
- Contribution to journal › Debate/Note/Editorial
- « previous
- 1
- 2
- 3
- 4
- next »